Synnova Intermediates is a young contract development and manufacturing organization (CDMO) based out of Hyderabad, India. We are founded by three technocrats backed by highly experienced management, technical team of scientists and engineers who specialize in niche, complex chemistry. We offer integrated services to pharma/biotech companies across their product life-cycle – from pre-clinical process development to small-scale clinical trial quantities and late-stage commercial manufacturing… Show more Synnova Intermediates is a young contract development and manufacturing organization (CDMO) based out of Hyderabad, India. We are founded by three technocrats backed by highly experienced management, technical team of scientists and engineers who specialize in niche, complex chemistry. We offer integrated services to pharma/biotech companies across their product life-cycle – from pre-clinical process development to small-scale clinical trial quantities and late-stage commercial manufacturing backed by advanced chemistry capabilities, state-of-the-art R&D centre, and a newly established cGMP compliant manufacturing site. Our primary value proposition lies in the synthesis and timely delivery of molecules, adhering to stringent timelines and exacting specifications. We are committed to maintaining the highest standards of quality, transparency, and integrity in all our operations. Show less

We manufacture and commission highly customized turn-key plants capable of catering all infra and housing segments. Our indigenous manufacturing of Jaw crushers, Cone crushers, VSIs, screens caters to projects ranging from 200 TPH to 500 TPH. Our core competency lies in technically understanding the customer requirements (in terms of desired aggregate size, shape characteristics) and customizing out plant layout to best match these needs. http://www.coreengg.co.in/

We are constantly on the lookout for companies with differentiated products / innovative technologies that can add value in India or has the potential to gain value from India.We work extensively across India (and Asia) for the CXO's of overseas SMEs by not only answering the critical questions they have for the market but also by developing their business. There are no pre-defined services but we work across the following domains:Strategic Research: Feasibility Analysis | Value… Show more We are constantly on the lookout for companies with differentiated products / innovative technologies that can add value in India or has the potential to gain value from India.We work extensively across India (and Asia) for the CXO's of overseas SMEs by not only answering the critical questions they have for the market but also by developing their business. There are no pre-defined services but we work across the following domains:Strategic Research: Feasibility Analysis | Value Chain Analysis | User Feedback | Pricing Strategy | Go To Market Strategy | Focus GroupBusiness Development: Partnerships | Procurement | Transaction SupportAdvisory: International Tax | Transfer Pricing | Laws and compliance | FinanceSector Focus- Industrial Goods and Services incl Chemicals | Healthcare & Pharmaceuticals | Media | FMCG Show less

• Developed novel tailor-made enzyme formulations effective against a diverse set of antibiotic resistant pathogens, killing up to 99.99% of the targeted pathogens • Demonstrated efficacy over conventional therapeutic approaches and established treatments mitigating antibiotic resistance, otherwise expected to reduce 0.5% of world’s GDP by 2020 ($1Trillion in terms of total output)• Managed and collaborated with 3 independent contributing towards 4 publications in reputed peer-reviewed… Show more • Developed novel tailor-made enzyme formulations effective against a diverse set of antibiotic resistant pathogens, killing up to 99.99% of the targeted pathogens • Demonstrated efficacy over conventional therapeutic approaches and established treatments mitigating antibiotic resistance, otherwise expected to reduce 0.5% of world’s GDP by 2020 ($1Trillion in terms of total output)• Managed and collaborated with 3 independent contributing towards 4 publications in reputed peer-reviewed journals. • Investigated the structural features on the enzyme that independently contribute to its specificity and activity • Rationally identified and engineered new enzymes with tailor-made specificity as well as enhanced activity• Created innovative strategies to decontaminate super-bugs such as Methicillin-resistant Staphylococcus aureus ($1Billion market) and filed 2 patent applications• Published a first author article in “Current Opinion in Biotechnology”, one of the most highly cited journals in this field • Presented research findings to an audience of over 300 professionals with diverse backgrounds • Worked in a team to conduct interviews with potential customers, suppliers in order to develop a deep knowledge of the pharmaceutical market and understand the key parameters influencing technology commercialization Show less

• Facilitated analysis of key determinants of plant operational costs as a part of a 5 member team• Suggested changes in the reactor feed composition that resulted in ~2% savings in the overall plant operation